Related Experiment Video
Updated: Mar 2, 2026
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
High-throughput screening and bioinformatic analysis to ascertain compounds that prevent saturated fatty acid-induced
Seung-Hee Lee1, Daniel Cunha2, Carlo Piermarocchi3
1Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Abstract:
Pancreatic β-cell lipotoxicity is a central feature of the pathogenesis of type 2 diabetes. To study the mechanism by which fatty acids cause β-cell death and develop novel approaches to prevent it, a high-throughput screen on the β-cell line INS1 was carried out. The cells were exposed to palmitate to induce cell death and compounds that reversed palmitate-induced cytotoxicity were ascertained. Hits from the screen were analyzed by an increasingly more stringent testing funnel, ending with studies on primary human islets treated with palmitate. MAP4K4 inhibitors, which were not part of the screening libraries but were ascertained by a bioinformatics analysis, and the endocannabinoid anandamide were effective at inhibiting palmitate-induced apoptosis in INS1 cells as well as primary rat and human islets. These targets could serve as the starting point for the development of therapeutics for type 2 diabetes.
Insights
Researchers identified compounds that protect pancreatic beta cells from fatty acid-induced death, a key factor in type 2 diabetes. Anandamide and MAP4K4 inhibitors show promise for developing new diabetes treatments.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cell Biology
Background:
- Pancreatic beta-cell lipotoxicity is a critical factor in type 2 diabetes development.
- Understanding the mechanisms of fatty acid-induced beta-cell death is crucial for therapeutic development.
Purpose of the Study:
- To investigate the mechanisms underlying fatty acid-induced beta-cell death.
- To identify novel compounds that can prevent beta-cell death.
Main Methods:
- High-throughput screening of compounds using the INS1 beta-cell line exposed to palmitate.
- A rigorous testing funnel to validate screening hits, including studies on primary human islets.
- Bioinformatics analysis to identify MAP4K4 inhibitors.
Main Results:
- Palmitate exposure induced cytotoxicity and apoptosis in INS1 cells and primary islets.
- Anandamide and MAP4K4 inhibitors effectively inhibited palmitate-induced apoptosis.
- These compounds demonstrated efficacy in both cell lines and primary human islets.
Conclusions:
- Anandamide and MAP4K4 inhibitors are effective in preventing lipotoxicity in pancreatic beta cells.
- These findings offer potential therapeutic targets for type 2 diabetes treatment.
